SkinIO Featured in Breakthroughs™ PSA Highlighting AI-Enhanced Skin Imaging and Rapid Connection to Dermatology Care

Multiple Public-service segments spotlight SkinIO’s breakthrough approach & mission to make early skin cancer detection simple and accessible for all.

CHICAGO , IL, UNITED STATES, September 3, 2026 /EINPresswire.com/ -- SkinIO, a skin cancer detection and connection-to-care innovator, is being featured in a national Breakthroughs™ Public Service Announcement focused on improving access to earlier skin cancer detection and helping more people take action on their skin health.

Skin cancer detection is one of the most important areas in preventive healthcare because timing matters. When people delay screening, cannot easily access dermatology care, or are unsure whether a skin change needs attention, small concerns can become more serious. The Breakthroughs™ PSA is designed to help educate the public about the importance of earlier detection, timely follow-up, and more accessible pathways to dermatology care.

SkinIO is making it easier for people to take action on their skin health. Using advanced imaging and artificial intelligence, SkinIO captures and analyzes skin images to help identify lesions or abnormalities that may warrant further evaluation. When a potential concern is identified, this innovative approach helps streamline the path to appropriate follow-up care—supporting earlier detection, faster action, and better access to care.

“SkinIO is honored to be featured as one of the breakthrough innovators in this PSA series,” said
Steve Bonner, CEO of SkinIO. “The series provides a careful and complete description of our
combination of AI-enhanced technology and rapid connection to care, explaining how earlier
detection and swift therapy can help reduce the burden of advanced-stage skin cancer.”
Bonner added, “We welcome continued feedback and conversation and look forward to sharing
more about our work to improve access, quality, cost, and outcomes in skin cancer detection and
care.”

The PSA frames SkinIO’s work within a larger public-health issue: awareness alone is not
enough if people cannot easily take the next step. For many individuals, access to a full skin
evaluation can be delayed by appointment availability, geography, cost concerns, lack of
awareness, or uncertainty about where to begin. SkinIO’s model helps make that first step more
approachable by combining technology-enabled skin imaging with a rapid connection to expert
dermatology care.

The PSA also emphasizes that AI-enhanced technology is not a replacement for clinical
judgment. Instead, it can be used as part of a responsible, connected process that helps identify
possible concerns and guide people toward appropriate professional evaluation. This distinction
is central to the public-service message: technology can help make detection more accessible, but
medical decision-making and follow-up care remain essential.

SkinIO’s mission is direct and ambitious: eradicate advanced-stage skin cancer by making early detection simple, accessible, and equitable for all. Their trusted AI-powered skin imaging and rapid connection to expert dermatology care bring breakthrough prevention to everyone, no matter where they are.

By featuring SkinIO, the Breakthroughs™ PSA series aims to help viewers understand that earlier skin cancer detection is not only a medical issue, but also an access issue. The goal is to encourage people to take skin health seriously, recognize that suspicious or changing lesions
deserve attention, and understand that more connected approaches to screening and follow-up can help reduce delays.

The PSA will reach both general and professional audiences nationally, including patients, families, employers, health plans, healthcare organizations, dermatology professionals, and public-health stakeholders interested in prevention, access, and earlier action.

About SkinIO

SkinIO is a skin cancer detection and connection-to-care innovator making it easier for people to
take action on their skin health. Using advanced imaging, artificial intelligence, and rapid
connection to expert dermatology care, SkinIO helps identify skin lesions or abnormalities that
may warrant further evaluation and supports a faster path to appropriate follow-up care.
For more info:
https://www.skinio.com/

About Breakthroughs™

Breakthroughs™ is a public-interest PSA series created to help audiences better understand
important advancements in science, medicine, technology, sustainability, infrastructure, and
human progress. Each segment translates complex innovation into clear, credible, visually
compelling public education — highlighting the larger human and societal impact behind
emerging ideas, technologies, and organizations helping shape the future.
For more info:
https://www.psabreakthroughs.org

Lisa Meyers
OMD prm
+1 305-974-1346
email us here

Watch the :60 SkinIO Preview PSA — a public-service message on earlier skin cancer detection, AI-enhanced imaging, and faster connection to dermatology care.